In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.

Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the progression of kidney disease, keeping kidney disease patients out of the ...

Diabetic nephropathy is a worldwide-leading cause of end-stage kidney disease resulting in dialysis or renal transplantation in about 20–40% of patients with diabetes patients (1). Additionally, such ...

A recent study from the University of Bristol has uncovered a potential new way to slow the progression of diabetic kidney disease, a condition that affects around 40% of people with diabetes.

You may lose weight because the body needs an energy source and burns fat and muscle instead. Type 1 diabetes is an autoimmune disease. This means the body's immune system mistakenly attacks healthy ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI ...

Long-term weight stability is recommended to improve health outcomes in individuals with type 1 diabetes. Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s diabetes-cum-weight ... injection on major kidney and cardiovascular outcomes in adults with Type 2 diabetes and chronic kidney ...

Diabetes can also mess with a person’s blood pressure and cause complications such as elevated blood pressure levels, which also damage the kidney. Causes and Symptoms of Kidney Disease Due to ...

Ozempic, the blockbuster GLP-1 drug ... type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker ...